Back to Portfolio

InSphero

The leading supplier of organotypic 3D microtissues - EXITED
 
InSphero

InSphero is the leading supplier of organotypic 3D microtissues for efficacy testing and toxicology in drug development. 3D microtissues have a significantly higher biological relevance than standard cellular monolayers.


Homepage Twitter YouTube  LinkedIn

 

InSphero in the News:

InSphero's CEO is Entrepreneur of the Year

Double-Digit Exit Multiple for Redalpine

InSphero in focus with their latest research publications

InSphero secures CHF 20m Series C financing

 

Jobs at InSphero